Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Harry Struijker-Boudier

Harry Struijker-Boudier
Department of Cardiovascular Research
Maastricht University
Maastricht, Netherlands

Harry Struijker-Boudier is  Professor Emeritus of Pharmacology at Maastricht University, The Netherlands. He graduated in 1973 in Pharmacochemistry and Biochemistry and obtained his Ph.D. in Pharmacology in 1975 from the Radboud University Nijmegen, the Netherlands.

Struijker-Boudier worked as a post-doc in the Department of Physiology and Biophysics of the University of Mississippi Medical School in Jackson, Miss., USA in 1976-1977 and took up a position in the newly created Department of Pharmacology at Maastricht University in 1977. He was appointed  Professor of Experimental Pharmacology in 1980 and as chairman of the Department of Pharmacology and Toxicology in 1984. He spent a sabbatical year as visiting professor at the INSERM Unit 141 at the Hôpital Lariboisière in Paris during 1991. From 1999-2006 he served as scientific director of the Cardiovascular Research Institute Maastricht (CARIM).

Struijker-Boudier has published more than 500 scientific papers in peer-reviewed international journals and books in the areas of cardiovascular pharmacology, hypertension, heart failure and drug design and delivery. The total number of citations of his articles is >25,000.

He has served as board member of numerous international organizations, e.g. vice-president of the scientific council of the European Society of Hypertension and board member of the European Federation of Pharmacological Societies. He is doctor honoris causa of the Université de Liège, Belgium, recipient of the Descartes-Huygens prize of the French Government, member of the Dutch Royal Society of Sciences and Officer of the Order of Oranje-Nassau of the Dutch Royal House.


Disclosure of faculty relationships

Harry Struijker-Boudier declared receipt of honoraria or consultation fees from Servier, Paris, Merck, Darmstadt, and Dutch-Flemish Accreditation Organization.

EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of EXCEMED. All presentations solely represent the independent views of the presenters/authors.